Düsseldorf, Germany - Beth: Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd. (Vazyme for short) is showcasing its advanced products and solutions related to COVID-19 testing in Hall 3, Stand F 94 at MEDICA 2021 Global Forum, the world's leading private trade fair. In the medical sector, it will be held in the trade fair grounds in Düsseldorf (Germany) from November 15 to November 18. This event showcases visitors a wide range of innovative medical products and solutions accompanied by brainstorming and expert panel sessions in specialized forums to better understand healthcare industry trends.

Vazyme unveils its full range of COVID-19 related products and solutions at the event with a focus on the debut of the company's latest virus testing product, the real-time PCR test for severe acute respiratory syndrome (SARS) 2 -CoV-2), Influenza A/B (FLU A/B RT-QPCR), and Rapid Test for Severe Acute Respiratory Syndrome and Influenza A/B (SARS-CoV-2 & FLU A/) Rapid Test B Ag), both of which are able to screen and detect all three types of viruses including COVID-19 and influenza A/B at the same time to maximize the effectiveness and comprehensiveness of virus testing.

Since the outbreak of the pandemic, Vazyme has continuously launched a series of COVID-19 test reagents and related devices for testing solutions for detection of nucleic acid, rapid antigens, rapid antibodies and rapid neutralizing antibodies. The company's products improve the detection of COVID-19 in the fight against this devastating epidemic with more accurate, reliable and rapid test results. Vazyme has provided COVID-19 test products and solutions to many countries and territories including Germany, United Kingdom, Russia, Brazil and Indonesia, and has supplied key raw materials for more than 500 million COVID-19 test kits to test instrument manufacturers Globally.

DNA Detection Solutions

A rapid test for SARS-CoV-2 antigens:

Home testing for SARS-CoV-2 antigens

Rapid test for SARS-CoV-2 antigens and influenza type A/B

Detection of neutralizing antibodies

The global in vitro diagnostics market has witnessed significant growth along with the demands of comprehensive, accurate and customized diagnostic solutions. Thanks to the company's years of product development experience in this field, Vazyme's in vitro diagnostic products cover many specialties including cardiology, antenatal and postnatal care, gastroenterology, nephrology, inflammation and pediatric pulmonology.

Apart from POCT diagnostic devices as a leading supplier of medical raw materials, Vazyme aims to provide its customers with the best products and services related to medical raw materials. As one of the top R&D-focused innovative producers in China with the capabilities of developing domestic progressive technologies and innovating finished products, Vazyme supports the vision of improving people's lives with technology and focuses on continuous investment in technological innovation and quality products.

To reach billions of customers globally, Vazyme is accelerating its expansion into foreign markets with a focus on developing the European market by building large-scale domestic operations. Vazyme is currently collaborating with world-renowned academic institutions to set up multinational laboratories and partnering with major medical and pharmaceutical distributors in overseas markets to build local sales and distribution networks. Vazyme looks forward to working with more global partners at the MEDICA 2021 Global Forum.